DEFA14A: Boundless Bio Sets Date for Annual Stockholders Meeting, Seeks Director Elections and Auditor Ratification
Proxy Statement
Boundless Bio will hold its annual stockholders meeting on June 23, 2025, to elect directors and ratify the appointment of KPMG LLP as its independent auditor.
Summary
- Boundless Bio, Inc. is holding its Annual Meeting of Stockholders on Monday, June 23, 2025, at 8:00 AM Pacific Time.
- The meeting will be held via live webcast, and stockholders can register and participate online.
- The agenda includes the election of Christine Brennan, Ph.D. and Nancy Whiting, Pharm.D. as directors.
- Stockholders will also vote to ratify the appointment of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
- The Board of Directors recommends a vote FOR each nominee and FOR Proposal 2.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, indicating a neutral to slightly positive sentiment as it reflects routine corporate governance processes.
Positives
- The meeting is being held via live webcast, providing accessibility for stockholders.
- The board is recommending a clear voting direction, which can simplify the decision-making process for stockholders.
Future Outlook
The document outlines the agenda for the upcoming annual meeting, focusing on governance matters such as director elections and auditor ratification, which are essential for the company's future operations and financial oversight.
Management Comments
- The Board of Directors recommends a vote FOR each nominee identified below and FOR Proposal 2.
Industry Context
This announcement is a standard corporate governance procedure for publicly traded companies. Holding annual meetings, electing directors, and ratifying auditors are routine activities to ensure accountability and transparency to shareholders.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | NA | Christine Brennan, Ph.D. | June 23, 2025 (if elected) | Election at Annual Meeting |
| Director | NA | Nancy Whiting, Pharm.D. | June 23, 2025 (if elected) | Election at Annual Meeting |
Stakeholder Impact
- Shareholders will have the opportunity to vote on key governance matters.
- The outcome of the votes will influence the composition of the Board of Directors and the selection of the independent auditor, impacting the company's oversight and financial reporting.
Next Steps
- Stockholders should review the proxy materials and vote on the proposals.
- The company will hold the Annual Meeting on June 23, 2025.
- The company will continue its operations under the oversight of the elected directors and the ratified auditor.
Key Dates
| Date | Description |
|---|---|
| April 25, 2025 | Stockholders of record date for the Annual Meeting |
| June 13, 2025 | Deadline to request paper copies of proxy materials in time for the meeting |
| June 23, 2025 | Date of the Annual Meeting of Stockholders |
| December 31, 2025 | Fiscal year end for which KPMG LLP is being considered as the independent auditor |
Keywords
Annual Meeting, Stockholders, Proxy Statement, Directors, Auditor, KPMG, Boundless Bio, Vote
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.